RecruitingNot ApplicableNCT04272515

Molecular Characterization for Understanding Biliary Atresia


Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Enrollment

100 participants

Start Date

Feb 7, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Although considered a rare disease, Biliary Atresia (BA) is the leading cause of neonatal cholestasis and liver transplantation in children. Little is known about the molecular mechanisms that drive BA. The purpose of this study is to collect the fluid samples, explanted liver tissue samples and dermal biopsy samples to enable investigators to perform the genetic and molecular analyses that might point to the gene(s) and cellular pathway involved in etiology of BA disease.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is conducting molecular (genetic and biological) research to better understand biliary atresia (BA), a rare and serious liver disease that affects newborns. In biliary atresia, the bile ducts — the tubes that carry bile from the liver to the intestine — are blocked or absent. Without treatment, the blocked bile destroys the liver. Currently, the cause of biliary atresia is not well understood. This study collects biological samples and data from affected children and their parents to look for genetic, immune, and environmental factors that might contribute to the condition, with the goal of developing better treatments. The study includes both children diagnosed with biliary atresia and their parents. There are no formal exclusion criteria listed — anyone with a confirmed BA diagnosis or who is a parent of an affected child may be eligible. You may be eligible if: - Your child has a confirmed diagnosis of biliary atresia, OR - You are the parent of a child with biliary atresia and are willing to provide biological samples for research You may NOT be eligible if: - There are no stated exclusion criteria for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERblood sampling

collection of blood sample for preparation of DNA

OTHERskin biopsy sampling

preparation of primary cultures of dermal fibroblasts from skin biopsy sample

OTHERexplanted liver of BA patients sampling

cryoconservation of liver tissue for molecular analyses


Locations(2)

Hopital Necker enfants malades

Paris, De, France

PRC Inserm

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04272515


Related Trials